3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
42
Lung Neoplasms
18
Melanoma
14
Carcinoma, Hepatocellular
14
Neoplasm Metastasis
13
Esophageal Neoplasms
11
Squamous Cell Carcinoma of Head and Neck
9
Breast Neoplasms
8
Head and Neck Neoplasms
6
Esophageal Squamous Cell Carcinoma
6
Rectal Neoplasms
5
Colorectal Neoplasms
5
Stomach Neoplasms
4
Recurrence
4
Neoplasms
4
Carcinoma, Renal Cell
4
Brain Neoplasms
4
Uterine Cervical Neoplasms
3
Triple Negative Breast Neoplasms
3
Small Cell Lung Carcinoma
3
Sarcoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Pancreatic Neoplasms
3
Multiple Myeloma
3
Cholangiocarcinoma
3
Carcinoma, Transitional Cell
3
Radiation Pneumonitis
2
Pathologic Complete Response
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Oropharyngeal Neoplasms
2
Interventions
sotigalimab
1
Surgical Procedures, Operative
1
Immunotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Locally Advanced Rectal Adenocarcinoma
×
Immunotherapy
×
Clear all
NCT07596290
2026-05-22
RADICAL
Beijing Friendship Hospital
Phase 2/3
Not yet recruiting
342 enrolled